Chapter 1: Introduction to Bacterial Gene Editing

The field of gene editing has been transformed by the CRISPR system, recognized as one of the most significant scientific breakthroughs of our era. Its application in healthcare is proving to be revolutionary, with researchers making significant strides in a remarkably short period. This past summer marked a milestone with the first-ever systemic delivery within a human body. Recent discussions have also highlighted the emergence of a compact version of CRISPR known as 'CasMINI'.

Recent advancements in health technology are being complemented by natural discoveries. Researchers from the McGovern Institute for Brain Research at MIT and the Broad Institute, in collaboration with Harvard University, have identified a new class of programmable DNA-modifying systems. This class, referred to as OMEGAs (Obligate Mobile Element Guided Activity), is believed to play a role in the natural shuffling of small DNA segments within bacterial genomes. These ancient enzymes, which cut DNA, are directed by small RNA molecules and are currently being adapted for use in human cells.

“We are thrilled by the discovery of these widespread programmable enzymes that have been overlooked until now. These findings suggest the exciting possibility that many more programmable systems are yet to be uncovered and could lead to significant technological advancements.”

~ Feng Zhang, Lead Researcher

Chapter 2: The Significance of OMEGAs

As demonstrated with CasMINI, OMEGAs are significantly smaller (approximately 30% the size of Cas9), making them easier to deliver than some of their larger counterparts. Research indicates that these natural RNA-guided enzymes are among the most prevalent proteins on Earth, highlighting a vast and unexplored domain of biology that is ready to propel the next wave of genome editing innovations.

Soumya Kannan, a graduate student fellow at the Yang-Tan Center for Molecular Therapeutics at MIT, collaborated with Han Altae-Tran on the study detailing the discovery of OMEGAs. This finding not only paves the way for future advancements but also hints at the existence of numerous other programmable enzymes in nature. These RNA-guided enzymes could be incredibly beneficial, as evidenced by the CRISPR system's effectiveness against viral threats.

Researchers were initially intrigued by IscB proteins, which resembled DNA-cutting enzymes but were not previously linked to CRISPR or RNA. The team found that each IscB had a nearby encoded small RNA that guided the enzyme to specific DNA sequences, which they termed "?RNAs." This led to the identification of two additional protein types, IsrBs and TnpBs, which also utilize ?RNAs to direct DNA cleavage.

All three of these proteins are part of mobile genetic elements known as transposons. As explained by a co-author of the study, each time these transposons move, they generate a new guide RNA, enabling the enzyme to cut DNA at different sites. While it remains unclear whether bacteria gain advantages from this genomic shuffling, if hosts can harness these systems, they could acquire new capabilities, including adaptive immunity.

IscBs and TnpBs are thought to be precursors to the Cas9 and Cas12 CRISPR systems. The research team believes that these proteins, alongside IsrB, likely contributed to the evolution of other RNA-guided enzymes—a discovery that excites the team. Just as scientists are addressing genetic challenges with CRISPR, these RNA-guided enzymes may represent nature’s solutions to similar biological issues.

This exploration has motivated the team to delve deeper into the evolutionary history of RNA-guided systems, potentially leading to the development of even more innovative programmable tools. The natural forms of these technologies could serve as an excellent foundation for crafting safe and effective medical treatments in the future.

Complete research findings were published in the Journal of Science.

Stay informed with the content that matters — Join my mailing list.